A shipment of Ebola vaccine doses has been delivered to the Democratic Republic of Congo as part of efforts to combat an outbreak linked to the less common Bundibugyo strain of the virus. Health officials are monitoring whether the vaccine, typically used against other Ebola variants, will provide protection in this case. The move follows concerns over the strain’s potential to spread undetected due to its milder symptoms compared to other forms. Authorities are urging vigilance as they assess the vaccine’s effectiveness in controlling the outbreak.
70,000 Ervebo vaccine doses have been sent to DR Congo in hope they prove effective against the Bundibugyo strain.
